Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 664
Filter
2.
N Engl J Med ; 390(4): 338-345, 2024 Jan 25.
Article in English | MEDLINE | ID: mdl-38265645

ABSTRACT

BACKGROUND: Hospitals can leverage their position between the ultimate buyers and sellers of drugs to retain a substantial share of insurer pharmaceutical expenditures. METHODS: In this study, we used 2020-2021 national Blue Cross Blue Shield claims data regarding patients in the United States who had drug-infusion visits for oncologic conditions, inflammatory conditions, or blood-cell deficiency disorders. Markups of the reimbursement prices were measured in terms of amounts paid by Blue Cross Blue Shield plans to hospitals and physician practices relative to the amounts paid by these providers to drug manufacturers. Acquisition-price reductions in hospital payments to drug manufacturers were measured in terms of discounts under the federal 340B Drug Pricing Program. We estimated the percentage of Blue Cross Blue Shield drug spending that was received by drug manufacturers and the percentage retained by provider organizations. RESULTS: The study included 404,443 patients in the United States who had 4,727,189 drug-infusion visits. The median price markup (defined as the ratio of the reimbursement price to the acquisition price) for hospitals eligible for 340B discounts was 3.08 (interquartile range, 1.87 to 6.38). After adjustment for drug, patient, and geographic factors, price markups at hospitals eligible for 340B discounts were 6.59 times (95% confidence interval [CI], 6.02 to 7.16) as high as those in independent physician practices, and price markups at noneligible hospitals were 4.34 times (95% CI, 3.77 to 4.90) as high as those in physician practices. Hospitals eligible for 340B discounts retained 64.3% of insurer drug expenditures, whereas hospitals not eligible for 340B discounts retained 44.8% and independent physician practices retained 19.1%. CONCLUSIONS: This study showed that hospitals imposed large price markups and retained a substantial share of total insurer spending on physician-administered drugs for patients with private insurance. The effects were especially large for hospitals eligible for discounts under the federal 340B Drug Pricing Program on acquisition costs paid to manufacturers. (Funded by Arnold Ventures and the National Institute for Health Care Management.).


Subject(s)
Blue Cross Blue Shield Insurance Plans , Fees, Pharmaceutical , Hospital Charges , Insurance, Health , Pharmaceutical Preparations , Humans , Blue Cross Blue Shield Insurance Plans/economics , Blue Cross Blue Shield Insurance Plans/statistics & numerical data , Health Personnel , Hospitals , Insurance Carriers , Physicians/economics , Insurance, Health/economics , Pharmaceutical Preparations/administration & dosage , Pharmaceutical Preparations/economics , Private Sector , Insurance Claim Review/economics , Insurance Claim Review/statistics & numerical data , United States/epidemiology , Infusions, Parenteral/economics , Infusions, Parenteral/statistics & numerical data , Economics, Hospital/statistics & numerical data , Professional Practice/economics , Professional Practice/statistics & numerical data
4.
J Contin Educ Nurs ; 53(7): 293-296, 2022 Jul.
Article in English | MEDLINE | ID: mdl-35858146

ABSTRACT

Gaining organizational commitment to build or expand a transition to practice program is greatly enhanced by following a business strategy that calls out an encompassing program return on investment (ROI). This article proposes the ROI categories that are powerful investment influencers for executives responsible for funding programs. The business strategy offers insight on how to connect workforce pipeline, retention, program accreditation/reimbursement, traveler replacement, improved quality measures, and career advancement data into a persuasive investment case. Additionally, for advanced practice residency/fellowships, additional categories of linking quality outcomes, billing and revenue generation, productivity, and procedural services are highlighted. [J Contin Educ Nurs. 2022;53(7):293-296.].


Subject(s)
Accreditation , Fellowships and Scholarships , Nursing , Professional Practice , Humans , Nursing/organization & administration , Professional Practice/economics , Professional Practice/organization & administration , Professional Practice/standards , Workforce
5.
J Arthroplasty ; 37(8): 1426-1430.e3, 2022 08.
Article in English | MEDLINE | ID: mdl-35026367

ABSTRACT

BACKGROUND: A survey was conducted at the 2021 Annual Meeting of the American Association of Hip and Knee Surgeons (AAHKS) to evaluate current practice management strategies among AAHKS members. METHODS: An application was used by AAHKS members to answer both multiple-choice and yes or no questions. Specific questions were asked regarding the impact of COVID-19 pandemic on practice patterns. RESULTS: There was a dramatic acceleration in same day total joint arthroplasty with 85% of AAHKS members performing same day total joint arthroplasty. More AAHKS members remain in private practice (46%) than other practice types, whereas fee for service (34%) and relative value units (26%) are the major form of compensation. At the present time, 93% of practices are experiencing staffing shortages, and these shortages are having an impact on surgical volume. CONCLUSION: This survey elucidates the current practice patterns of AAHKS members. The pandemic has had a significant impact on some aspects of practice activity. Future surveys need to monitor changes in practice patterns over time.


Subject(s)
Ambulatory Surgical Procedures , Arthroplasty, Replacement, Hip , Arthroplasty, Replacement, Knee , COVID-19 , Health Workforce , Orthopedics , Practice Management , Ambulatory Surgical Procedures/statistics & numerical data , Arthroplasty, Replacement, Hip/economics , Arthroplasty, Replacement, Hip/methods , Arthroplasty, Replacement, Hip/statistics & numerical data , Arthroplasty, Replacement, Knee/economics , Arthroplasty, Replacement, Knee/methods , Arthroplasty, Replacement, Knee/statistics & numerical data , COVID-19/epidemiology , Delivery of Health Care/statistics & numerical data , Health Care Surveys/statistics & numerical data , Health Workforce/statistics & numerical data , Humans , Orthopedics/economics , Orthopedics/organization & administration , Orthopedics/statistics & numerical data , Pandemics , Practice Management/economics , Practice Management/organization & administration , Practice Management/statistics & numerical data , Practice Patterns, Physicians'/economics , Practice Patterns, Physicians'/organization & administration , Practice Patterns, Physicians'/statistics & numerical data , Professional Practice/economics , Professional Practice/organization & administration , Professional Practice/statistics & numerical data , United States/epidemiology
7.
J Health Polit Policy Law ; 46(4): 731-745, 2021 08 01.
Article in English | MEDLINE | ID: mdl-33493336

ABSTRACT

Organized medicine's persistent demand for high payments is one factor that contributes to the rising costs of health care. The profession's long-standing preference for private and fee-for-service practice has pressured payers to increase reimbursement rates in fee-based systems; and it has stalled, thwarted, or otherwise co-opted attempts to contain costs in other payment systems. Yet what doctors want in fact varies. This article revisits classic comparative studies of organized medicine in advanced democracies to highlight two underemphasized findings: (1) physicians' financial preferences can deviate from traditional expectations, and (2) the structure of the organizations that represent doctors can shape whether and how those preferences are expressed. These findings remain relevant today as a discussion of contemporary American health politics illustrates.


Subject(s)
American Medical Association/economics , Delivery of Health Care/economics , Physicians/economics , Professional Practice/economics , Europe , Humans , Reimbursement Mechanisms , United States
8.
Clin Neuropsychol ; 35(1): 7-80, 2021 01.
Article in English | MEDLINE | ID: mdl-33375892

ABSTRACT

OBJECTIVE: This portion of the 2020 survey updates practice information, beliefs, and income data of clinical neuropsychologists who practice within the United States. Methods: Doctoral-level neuropsychology practitioners were invited via numerous methods, with multiple reminders, to participate in a web-based survey from January 17 through April 2, 2020. The useable U.S. sample of 1677 doctoral-level practitioners was 6.2% larger than the comparable group in the prior 2015 practice survey. Results: Whereas women practitioners predominate, which continues a steeply increasing trend across time, increases in overall ethnic/racial diversity continue at a slow pace. Median age has remained very similar over the last 30 years, reflecting a continuous influx of young practitioners. A relatively small minority of neuropsychologists work part time. The proportion of board-certified neuropsychologists continues to show meaningful increase; interest in subspecialization certification is relatively high. Reliance on technicians remains popular, especially for neuropsychologists who work in institutions or are board certified. Although implementation of new CPT codes in 2019 and related payor policies appear to have had more negative than positive effects, psychology-related annual incomes of neuropsychologists have again increased compared to prior surveys. Variables such as specific work setting, state, region, years in practice, forensic practice hours, board certification, and basis for determining income (e.g. hours billed, revenue collected, relative value units) have an impact on income. More than half of practitioners engage in forensic neuropsychology, with the number of related practice hours per week again increasing. There is very high agreement regarding the use of response validity measures in clinical practice and forensic practice. Neurologists remain the number one referral source whether working in an institution, private practice, or a combination of both, and regardless of maintaining a pediatric, adult, or lifespan practice. Career satisfaction ratings for income, job, and work-life balance remain high, with the majority of ratings regarding the future of the specialty in the positive range. Additional data summaries related to a wide range of professional and practice topics are provided. Conclusions: Updating and comparing survey information at five-year intervals continues to provide insights and perspectives regarding relative stabilities and changes in practice activities, beliefs, and incomes of U.S. clinical neuropsychologists. Such information also provides guidance regarding the future of the specialty.


Subject(s)
Attitude of Health Personnel , Income/statistics & numerical data , Neuropsychology/economics , Professional Practice/economics , Salaries and Fringe Benefits/economics , Adult , Employment/economics , Female , Humans , Male , Neuropsychology/statistics & numerical data , Professional Practice/statistics & numerical data , Salaries and Fringe Benefits/statistics & numerical data , Surveys and Questionnaires , United States , Workplace
10.
Tex Med ; 116(8): 20-25, 2020 Aug 01.
Article in English | MEDLINE | ID: mdl-32866271

ABSTRACT

Ricardo Garza, MD, was still walking the tightrope: standing, but unable to withstand another gust of wind. COVID-19 swept away about 35% of the San Antonio solo cardiologist's practice revenue, and that was just what he could calculate as he waited for insurers to process straggling claims. But he had returned to in-office operations without any layoffs. While some practices are surviving - and trying their best to prepare for future threats - others weren't so lucky. On-the-ground experiences align with the Texas Medical Association's Practice Viability Survey in showing COVID-19 was, and still is, a disruptor unlike any other - challenging or torpedoing the viability of various practice types.


Subject(s)
Communicable Disease Control/methods , Coronavirus Infections , Pandemics , Pneumonia, Viral , Professional Practice , Telemedicine , Betacoronavirus , COVID-19 , Coronavirus Infections/economics , Coronavirus Infections/epidemiology , Decision Making, Organizational , Disease Transmission, Infectious/prevention & control , Humans , Organizational Innovation , Pandemics/economics , Pneumonia, Viral/economics , Pneumonia, Viral/epidemiology , Practice Patterns, Physicians'/organization & administration , Practice Patterns, Physicians'/trends , Professional Practice/economics , Professional Practice/trends , SARS-CoV-2 , Texas/epidemiology
11.
Sleep Med Clin ; 15(3): 347-358, 2020 Sep.
Article in English | MEDLINE | ID: mdl-32762968

ABSTRACT

Synchronous telemedicine allows clinicians to expand their reach by using technology to take care of patients who otherwise may not be seen. Establishing a telemedicine practice can be daunting. This article outlines how to implement a synchronous telemedicine practice into an existing workflow. Telemedicine-specific considerations are discussed, as well as guidance regarding practice assessment, financial feasibility, technical considerations, and clinical guidance to translate in-person visit skills into an effective virtual visit.


Subject(s)
Professional Practice/organization & administration , Telemedicine/organization & administration , Humans , Professional Practice/economics , Telemedicine/economics
13.
Rheum Dis Clin North Am ; 46(1): 119-133, 2020 02.
Article in English | MEDLINE | ID: mdl-31757280

ABSTRACT

Physicians in training and their mentors must be cognizant of ethical concerns related to industry interactions. Mentors perceived to have conflicts of interest or to be engaging in misconduct can unconsciously and profoundly affect the learning and academic environment by implying certain values and expectations. Despite increased awareness of ethical concerns related to industry interactions in clinical practice and research, there remains a need for interventions to prevent ethical transgressions. Ethics education is essential and a move in the right direction, but it alone is likely inadequate in preventing unethical behavior. Education should be supplemented with ethical environments at institutions.


Subject(s)
Drug Industry/ethics , Education, Medical/ethics , Ethics, Clinical , Professional Practice/ethics , Research Support as Topic/ethics , Rheumatology/ethics , Bioethical Issues/standards , Biomedical Research/economics , Biomedical Research/education , Biomedical Research/ethics , Conflict of Interest/economics , Curriculum/standards , Drug Industry/economics , Ethics, Clinical/education , Mentoring/ethics , Patient Care/economics , Patient Care/ethics , Patient Care/standards , Professional Practice/economics , Professional Practice/standards , Rheumatology/economics , Rheumatology/education , Training Support/economics , Training Support/ethics
14.
J Biomed Inform ; 98: 103272, 2019 10.
Article in English | MEDLINE | ID: mdl-31479747

ABSTRACT

INTRODUCTION: With the growth in Internet technology, online rating websites encourage patients to contribute actively in rating their physicians. These rating sites provide more information for patients, such as electronic word of mouth (eWOM) and physician trustworthiness. Although several studies in e-commerce have investigated the role of eWOM and seller trustworthiness in the consumer purchase decision-making process and the price premium for products or services, studies on the role of different information sources that reflect the service quality and delivery process in choosing a competent physician remain scarce. This research develops a two-equation model to examine the effect of different signals, i.e., patient-generated signals (PGSs) and system-generated signals (SGSs), on patient choice, which is an important predictor of physicians' economic returns. METHODS: A secondary data econometric analysis and structural modeling using 2896 physicians' real data from a publicly available online physician rating site, i.e., Healthgrades.com, were conducted using a mixed-methods approach. A hybrid text mining approach was adopted to calculate the sentiment of each review. RESULTS: We find that both PGSs and SGSs have a significant impact on patient choice at different stages of health consultation. Furthermore, disease risk negatively moderates the association between PGSs and information search, while the impact of both signals on patient willingness to pay a price premium is positively moderated by the disease risk. CONCLUSION: Our study contributes to the unified framework of signaling theory and Maslow's hierarchy of needs theory by making a clear distinction between PGSs or SGSs and their influence on patient decision-making across different disease risks. Moreover, PGSs and SGSs are two essential factors for physicians to increase their income.


Subject(s)
Patient Satisfaction , Physicians/economics , Professional Practice/economics , Algorithms , Commerce , Data Mining , Decision Making , Economics, Medical , Humans , Income , Internet , Models, Econometric , Physician-Patient Relations , Physicians/statistics & numerical data , Social Media , Surveys and Questionnaires , United States
16.
Oncologist ; 24(5): 632-639, 2019 05.
Article in English | MEDLINE | ID: mdl-30728276

ABSTRACT

BACKGROUND: Financial relationships between physicians and the pharmaceutical industry are common, but factors that may determine whether such relationships result in physician practice changes are unknown. MATERIALS AND METHODS: We evaluated physician use of orally administered cancer drugs for four cancers: prostate (abiraterone, enzalutamide), renal cell (axitinib, everolimus, pazopanib, sorafenib, sunitinib), lung (afatinib, erlotinib), and chronic myeloid leukemia (CML; dasatinib, imatinib, nilotinib). Separate physician cohorts were defined for each cancer type by prescribing history. The primary exposure was the number of calendar years during 2013-2015 in which a physician received payments from the manufacturer of one of the studied drugs; the outcome was relative prescribing of that drug in 2015, compared with the other drugs for that cancer. We evaluated whether practice setting at a National Cancer Institute (NCI)-designated Comprehensive Cancer Center, receipt of payments for purposes other than education or research (compensation payments), maximum annual dollar value received, and institutional conflict-of-interest policies were associated with the strength of the payment-prescribing association. We used modified Poisson regression to control confounding by other physician characteristics. RESULTS: Physicians who received payments for a drug in all 3 years had increased prescribing of that drug (compared with 0 years), for renal cell (relative risk [RR] 1.81, 95% confidence interval [CI] 1.58-2.07), CML (RR 1.22, 95% CI 1.08-1.39), and lung (RR 1.69, 95% CI 1.58-1.82), but not prostate (RR 0.97, 95% CI 0.93-1.02). Physicians who received compensation payments or >$100 annually had increased prescribing compared with those who did not, but NCI setting and institutional conflict-of-interest policies were not consistently associated with the direction of prescribing change. CONCLUSION: The association between industry payments and cancer drug prescribing was greatest among physicians who received payments consistently (within each calendar year). Receipt of payments for compensation purposes, such as for consulting or travel, and higher dollar value of payments were also associated with increased prescribing. IMPLICATIONS FOR PRACTICE: Financial payments from pharmaceutical companies are common among oncologists. It is known from prior work that oncologists tend to prescribe more of the drugs made by companies that have given them money. By combining records of industry gifts with prescribing records, this study identifies the consistency of payments over time, the dollar value of payments, and payments for compensation as factors that may strengthen the association between receiving payments and increased prescribing of that company's drug.


Subject(s)
Antineoplastic Agents/therapeutic use , Drug Industry/economics , Neoplasms/drug therapy , Oncologists/statistics & numerical data , Professional Practice/statistics & numerical data , Administration, Oral , Antineoplastic Agents/economics , Antineoplastic Agents/standards , Conflict of Interest/economics , Datasets as Topic , Drug Prescriptions/economics , Drug Prescriptions/standards , Drug Prescriptions/statistics & numerical data , Female , Humans , Male , Medical Oncology/economics , Medical Oncology/ethics , Medical Oncology/standards , Medical Oncology/statistics & numerical data , National Cancer Institute (U.S.)/standards , Neoplasms/economics , Oncologists/economics , Oncologists/ethics , Professional Practice/economics , Professional Practice/ethics , Professional Practice/standards , United States
17.
Clin Neuropsychol ; 33(1): 13-31, 2019 01.
Article in English | MEDLINE | ID: mdl-29749793

ABSTRACT

OBJECTIVE: The National Association of Psychometrists (NAP) conducted a salary survey to collect data regarding common practices and income of individuals employed as psychometrists. METHODS: An email with a survey link was sent to NAP members and posted on the NAP website. There were 118 responses; most from the United States. RESULTS: Canadian data was excluded from compensation analysis due to imprecision in the survey/exchange rates. Most respondents reported full time employment. Respondents' educations were equally split between bachelor's and master's degrees. More than half reported hourly compensation. Most psychometrists see one patient a day and the most frequent age range was adults between 17-59 years old. Administration times ranged from 3-5 h, except in young pediatric populations. Two hours was the most commonly reported amount of time needed to score a test battery. The average hourly wage was $23.00 ± 4.96. Certified psychometrists reported higher average hourly wages (M = 24.57, SD = 4.73) compared to those who are not certified (M = 21.53, SD = 4.76). This difference was statistically significant (p < .001) with a medium effect size (d = .64). Results of the survey also showed a significant increase in income based on years of experience as a psychometrist. CONCLUSIONS: The current survey may be used as a baseline for further study of the income and practices of psychometrists in the United States and Canada.


Subject(s)
Neuropsychological Tests/standards , Professional Practice/economics , Professional Practice/standards , Psychometrics/methods , Adolescent , Adult , Canada , Female , History, 21st Century , Humans , Income , Male , Middle Aged , Surveys and Questionnaires , United States , Young Adult
19.
Lakartidningen ; 1152018 05 24.
Article in Swedish | MEDLINE | ID: mdl-29809273

ABSTRACT

The application of economic incentives to providers in health care governance is debated. Advocates argue that it drives efficiency and improvement, opponents claim that it leads to unintended consequences for patients and professionals. Research shows that incentives can increase well-defined activities and targets, but there is a lack of substantial evidence that applications in health care lead to desired outcomes. The motivational literature acknowledges internal sources of motivation as important determinants of behavior, and the literature about professions suggests that professional values of serving patient needs is a key motivator. The management literature identifies the important role of leaders in aligning external demands and rewards to staff preferences, using their own management and leadership skills. Findings in health services research confirm the vital role of leaders for successful implementation and improvement work. In sum, internal motivators and the role of leaders are important to acknowledge also when understanding how economic governance models are put into practice.Our recently published qualitative case study provides empirical examples of how clinical leaders function as intermediaries between a local care choice model, including financial incentives, and the motivation of staff. The strategies deployed by the leaders aimed to align the economic logics of the model to the professional focus on increasing patient value. The main conclusion from these empirical examples, as well as previous research, is that health care managers play a key role in aligning economic incentive models with professional values and in translating such models in to feasible tasks related to the provision of high quality care.


Subject(s)
Leadership , Motivation , Reimbursement Mechanisms , Delivery of Health Care/economics , Delivery of Health Care/organization & administration , Humans , Professional Practice/economics , Quality Assurance, Health Care
20.
Vaccine ; 36(8): 1093-1100, 2018 02 14.
Article in English | MEDLINE | ID: mdl-29366706

ABSTRACT

BACKGROUND: Financial concerns are often cited by physicians as a barrier to administering routinely recommended vaccines to adults. The purpose of this study was to assess perceived payments and profit from administering recommended adult vaccines and vaccine purchasing practices among general internal medicine (GIM) and family medicine (FM) practices in the United States. METHODS: We conducted an interviewer-administered survey from January-June 2014 of practices stratified by specialty (FM or GIM), affiliation (standalone or ≥ 2 practice sites), and level of financial decision-making (independent or larger system level) in FM and GIM practices that responded to a previous survey on adult vaccine financing and provided contact information for follow-up. Practice personnel identified as knowledgeable about vaccine financing and billing responded to questions about payments relative to vaccine purchase price and payment for vaccine administration, perceived profit on vaccination, claim denial, and utilization of various purchasing strategies for private vaccine stocks. Survey items on payment and perceived profit were assessed for various public and private payer types. Descriptive statistics were calculated and responses compared by physician specialty, practice affiliation, and level of financial decision-making. RESULTS: Of 242 practices approached, 43% (n = 104) completed the survey. Reported payment levels and perceived profit varied by payer type. Only for preferred provider organizations did a plurality of respondents report profiting on adult vaccination services. Over half of respondents reported losing money vaccinating adult Medicaid beneficiaries. One-quarter to one-third of respondents reported not knowing about Medicare Part D payment levels for vaccine purchase and vaccine administration, respectively. Few respondents reported negotiating with manufacturers or insurance plans on vaccine purchase prices or payments for vaccination. CONCLUSIONS: Practices vaccinating adults may benefit from education and technical assistance related to vaccine financing and billing and greater use of purchasing strategies to decrease upfront vaccine cost.


Subject(s)
Insurance, Health, Reimbursement/economics , Professional Practice/economics , Vaccination/economics , Vaccines/economics , Adult , Chi-Square Distribution , Costs and Cost Analysis , Follow-Up Studies , Humans , Medicaid/statistics & numerical data , Medicare/statistics & numerical data , Physicians , United States
SELECTION OF CITATIONS
SEARCH DETAIL
...